Related Experiment Video

Updated: May 11, 2026

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
16:59

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer

Published on: October 10, 2012

Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice

Tohru Uchida1, Takehiro Nakamura, Naoko Hashimoto

  • 1Division of Diabetes and Digestive and Kidney Diseases, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.

Nature Medicine
|February 3, 2005
PubMed

Insights

The protein p27(Kip1) accumulates in pancreatic beta cells, worsening type 2 diabetes. Removing p27(Kip1) improved diabetes by boosting beta-cell proliferation and mass.

Area of Science:

  • Cell Biology
  • Endocrinology
  • Molecular Biology

Background:

  • p27(Kip1) is a key regulator of cell cycle progression in mammals.
  • Dysregulation of pancreatic beta cells is central to type 2 diabetes mellitus.
  • Insulin receptor substrate 2 (Irs2) and leptin receptor (Lepr) signaling are critical for beta cell function.

Purpose of the Study:

  • To investigate the role of p27(Kip1) in pancreatic beta cell dysfunction in mouse models of type 2 diabetes.
  • To determine if targeting p27(Kip1) can ameliorate hyperglycemia and improve beta cell mass.

Main Methods:

  • Studied p27(Kip1) nuclear accumulation in pancreatic beta cells of Irs2(-/-) and Lepr(-/-) mice.
  • Utilized gene deletion of p27(Kip1) (Cdkn1b) in these diabetic mouse models.
  • Assessed changes in islet mass, insulin levels, and beta cell proliferation.

Main Results:

  • p27(Kip1) progressively accumulated in the nucleus of pancreatic beta cells in Irs2(-/-) and Lepr(-/-) mice.
  • Deletion of Cdkn1b ameliorated hyperglycemia in these models.
  • p27(Kip1) deletion increased islet mass and maintained compensatory hyperinsulinemia, primarily by stimulating beta cell proliferation.

Conclusions:

  • p27(Kip1) contributes to pancreatic beta cell failure in the development of type 2 diabetes.
  • p27(Kip1) is a potential therapeutic target for treating type 2 diabetes mellitus.
  • Modulating p27(Kip1) levels can enhance beta cell proliferation and improve glycemic control.

More Related Videos

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.